Florence, SC, United States of America

Joachim Veits

This inventor holds 2 USPTO granted patents. Top assignees: Hoffmann-La Roche Inc., Roche Vitamins Inc.. Active years: 2001-2015.


% Patents Active = 50.0

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2001-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Joachim Veits: Innovator in Pharmaceutical Chemistry

Introduction

Joachim Veits is a notable inventor based in Florence, SC (US), recognized for his contributions to pharmaceutical chemistry. He holds 2 patents that focus on processes for the preparation of important chemical compounds.

Latest Patents

Veits' latest patents include a process for the preparation of cyclohexanecarboxylic acid derivatives. This process is significant as it provides an intermediate useful in the synthesis of pharmaceutically active compounds. Another notable patent is directed towards the production of biotin, specifically a process for creating 2-oxo-1,3-dibenzyl-cis-4,5-imidazolidinedicarboxylic acid and its anhydride. This process involves a series of reactions starting from meso-2,3-bis(benzylamino)succinic acid dialkali metal salt, showcasing his expertise in complex chemical synthesis.

Career Highlights

Throughout his career, Veits has worked with prominent companies such as Hoffmann-La Roche Inc. and Roche Vitamins Inc. His experience in these organizations has contributed to his innovative work in the field of pharmaceuticals.

Collaborations

Veits has collaborated with notable professionals in the industry, including Andreas Staempfli and Christian Lautz. These collaborations have likely enhanced his research and development efforts.

Conclusion

Joachim Veits is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the preparation of vital compounds. His patents reflect his innovative spirit and dedication to improving pharmaceutical processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…